You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) PEG-5 OLEATE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing PEG-5 OLEATE excipient

Market Dynamics and Financial Trajectory for PEG-5 Oleate

Last updated: February 8, 2026

Overview

PEG-5 Oleate is a non-ionic surfactant used primarily as an emulsifier, solubilizer, and wetting agent in pharmaceuticals, cosmetics, and food applications. Its market position depends on factors including demand from end-use industries, regulatory environment, and supply chain developments.

Market Size and Growth Drivers

The global pharmaceutical excipient market was valued at approximately $9 billion in 2022, with surfactants like PEG-5 Oleate constituting a significant segment. The compound's growth is driven by increasing demand for topical formulations, injectable emulsions, and cosmetic products.

The compound's specific market share remains proprietary, but surfactants account for roughly 30% of the pharmaceutical excipient market, with growth estimated at 4-6% CAGR through 2027. PEG derivatives, including PEG-5 Oleate, are favored due to their favorable safety profile and compatibility with active pharmaceutical ingredients (APIs).

Key Demand Factors

  • Pharmaceutical Industry Expansion: Growth in topical and injectable drugs requiring emulsification.
  • Cosmetic Industry Growth: Increasing use in skincare and personal care due to emulsifying properties.
  • Regulatory Acceptance: Approval by agencies such as FDA and EMA sustains market confidence.
  • Evolving Formulation Technologies: Shift toward surfactants with lower toxicity and higher efficacy.

Supply Chain and Manufacturing Trends

Major producers include benchmarks like BASF, Evonik, and Croda. Manufacturing depends on oleic acid sources, primarily derived from vegetable oils, and PEG synthesis processes. Supply disruptions due to raw material shortages or regulatory changes influence pricing and availability.

Pricing and Revenue Trends

While specific PEG-5 Oleate pricing is proprietary, typical unit prices range from $8 to $15 per kilogram, influenced by purity levels, supplier location, and quantity ordered. The compound's relatively niche application class results in moderate pricing volatility.

Regulatory Impact

PEG derivatives are generally regarded as safe at specified concentrations. However, increased scrutiny around PEG-associated toxicity and environmental considerations could influence regulatory approvals and market access, especially within cosmetic markets.

Future Market Trajectory

Projected demand growth hinges on advancements in formulation science and regulatory policies. Emerging areas include transdermal drug delivery systems and nanoparticle formulations, which may elevate PEG-5 Oleate’s relevance.

Financial Outlook and Investment Considerations

Companies with established manufacturing capacity and R&D pipelines for PEG-based excipients will benefit from rising demand. The market is expected to grow steadily, with a compound annual growth rate (CAGR) of around 4-6% through 2027.

Vertical integration strategies, geographic expansion into emerging markets, and sustainability practices are key to enhancing margins. The influence of regulatory trends may compel firms to develop greener manufacturing processes or alternative surfactants, impacting long-term profitability.

Competitive Landscape

Top producers include:

  • BASF (Germany)
  • Evonik Industries (Germany)
  • Croda International (UK)
  • Dow Chemical (US)

These firms compete on product purity, price, and development of tailored excipients.

Summary Table

Aspect Details
Market size (2022) ~$9 billion (pharmaceutical excipients)
Surfactant segment ~30% of excipient market
PEG-5 Oleate pricing $8–$15/kg depending on specs
CAGR (2022–2027) 4–6%
Key manufacturers BASF, Evonik, Croda

Key Takeaways

  • PEG-5 Oleate maintains a significant role in pharmaceutical and cosmetic formulations.
  • Growth is primarily driven by expanding markets for topical drugs and skincare products.
  • Pricing remains moderate but can fluctuate with raw material and regulatory developments.
  • Regulatory scrutiny over PEG compounds may alter supply and product formulations.
  • Larger players focus on sustainable and innovative manufacturing methods to sustain competitive advantage.

Frequently Asked Questions

1. What are the main applications of PEG-5 Oleate?
It is mainly used as an emulsifier and solubilizing agent in topical pharmaceuticals, injectables, and cosmetics.

2. How does regulatory scrutiny influence the PEG-5 Oleate market?
Regulatory agencies review PEG compounds for toxicity and environmental impact, which could lead to restrictions or the development of alternative excipients.

3. What factors could disrupt supply chains?
Raw material shortages (vegetable oils/oleic acid), regulatory changes, and geopolitical issues.

4. How does PEG-5 Oleate compare to alternative surfactants?
It offers a good safety profile and compatibility, but newer bio-based or synthetic surfactants may emerge as substitutes if they demonstrate higher efficacy or lower regulatory risk.

5. What is the outlook for companies primarily producing PEG-5 Oleate?
Growth prospects are favorable, especially for firms investing in sustainable manufacturing and expanding into emerging markets.


Citations:
[1] MarketsandMarkets. "Pharmaceutical excipients market." 2022.
[2] Grand View Research. "Surfactants Market Size & Share." 2023.
[3] U.S. FDA. "Overview of PEG compounds and safety considerations," 2022.
[4] Company financial reports and industry analysis from BASF, Evonik, Croda.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.